Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report and review of the literature.

Lara Vera, Silvia Oddo, Natascia Di Iorgi, Giorgio Bentivoglio, Massimo Giusti

Journal: Journal of medical case reports 2017;10(1):361

PMID: 27998296

Abstract

BACKGROUND

The efficacy and safety of various modes of medical treatment for primary hyperparathyroidism in pregnancy are largely unknown.

CASE PRESENTATION

We report the case of a 34-year-old white woman with primary hyperparathyroidism symptomatic for nephrolithiasis. Her serum calcium was 3.15 mmol/l and parathyroid hormone was 109.0 ng/L. Neck imaging found no pathological parathyroid tissue. Cinacalcet and cholecalciferol were started. She became pregnant 17 months later. The calcimimetic was stopped. During pregnancy, she was admitted for hydration administered intravenously two to three times per week. In her 24 week of pregnancy, cinacalcet was restarted. In her 32nd week, a cesarean section was carried out as planned.

CONCLUSIONS

Only three cases of primary hyperparathyroidism in women on cinacalcet therapy in pregnancy have been published in the literature. In the present case, hydration was useful in controlling serum calcium. Cinacalcet therapy helped to control serum calcium.

Address: Department of Internal Medicine, Genoa University, Viale Benedetto XV 6, 16132, Genoa, Italy.; Department of Pediatrics, IRCC G. Gaslini, Genoa, Italy.; Department of Obstetrics and Gynecology, IRCC G. Gaslini, Genoa, Italy.; Department of Internal Medicine, Genoa University, Viale Benedetto XV 6, 16132, Genoa, Italy. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.